Developing new vaccines to fight tuberculosis
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis
This study is working on new and better vaccines for tuberculosis (TB) to help protect people more effectively than the current vaccine, so that patients can have improved options for preventing this serious disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Biomedical Research Institute NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-10834753 on NIH RePORTER |
What this research studies
This research focuses on creating innovative vaccines to combat tuberculosis (TB), a disease that has claimed millions of lives. The project aims to identify and develop new vaccine candidates that can provide better protection against TB than the currently available vaccine. Researchers will explore combining specific protein antigens with new adjuvants to enhance immune responses and utilize novel RNA technology to create effective vaccines. Patients may benefit from improved vaccination options that could lead to better prevention of TB.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for tuberculosis, including those in endemic regions or with compromised immune systems.
Not a fit: Patients who are already infected with tuberculosis and require immediate treatment may not benefit directly from this vaccine-focused research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that significantly reduce the incidence and transmission of tuberculosis.
How similar studies have performed: Previous research has shown promise in developing new vaccine strategies for tuberculosis, indicating potential for success in this innovative approach.
Where this research is happening
San Antonio, United States
- Texas Biomedical Research Institute — San Antonio, United States (Active)
Researchers
- Principal investigator: Beamer, Gillian L — Texas Biomedical Research Institute
- Study coordinator: Beamer, Gillian L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.